Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
NurExone Biologic, with offices in Canada and Israel, reported Dec. 6 findings of a preclinical study of its lead candidate, ExoPTEN, for repairing optic nerve damage. Researchers utilized a rodent...
ViaLase of Aliso Viejo, California, reported Dec. 10 that it would partner with the John A. Moran Eye Center at the University of Utah to explore the effect of creating multiple channels in the tra...
The National Institutes of Health (NIH) is joining the push to fund the development of technologies and biomarkers to diagnose systemic disease through the eye, a field known as oculomics. The NIH ...
A surgical team at NYU Langone Health performed the world’s first whole eye and partial-face transplant in May 2023 for Aaron James, who had survived a high-voltage electrical accident at work. Ove...
The Advanced Research Projects Agency for Health (ARPA-H) announced Dec. 2 that it would pledge up to $125 million from its Transplantation of Human Eye Allografts (THEA) program to advance researc...
The Advanced Research Projects Agency for Health (ARPA-H) announced Dec. 2 that it would pledge up to $125 million from its Transplantation of Human Eye Allografts (THEA) program to advance researc...
Science Corporation, of Alameda, California, reported Oct. 22 preliminary results that showed its Prima retinal implant allowed for functional vision in patients who had lost their central visual f...
Heidelberg Engineering announced Oct. 14 that the US FDA had granted 510(k) clearance to its Flex Module for the Spectralis diagnostic imaging platform. The Flex Module mounts the Spectralis to a m...
Genentech, a member of the Roche Group, announced Oct. 18 positive topline one-year results from the postmarket Elevatum study evaluating Vabysmo (faricimab-svoa) for the treatment of diabetic macu...
ARPA-H announced Oct. 18 that it had launched a new program to develop a tear-based biomarker measurement system that can be inserted into the tear duct to provide continuous health monitoring, pai...
Barcelona-basedGrifols reported Oct. 22 that it is partnering with the US government’s BARDA to test ocular surface immunoglobulin (OSIG) eye drops for their ability to treat ocular damage from sul...
Researchers at the National Eye Institute (NEI), working with counterparts in China, have discovered a reversible cataract response in hibernating squirrels that may point toward a nonsurgical trea...
A surgical team at NYU Langone Health performed the world’s first whole eye and partial-face transplant in May 2023 for Aaron James, who had survived a high-voltage electrical accident at work. Ove...
OcuDyne, of Brooklyn Park, Minnesota, reported Sept. 9 that it had successfully completed a pilot study using its Optic System to perform ophthalmic artery angioplasty in patients with geographic a...
A study in mice at the Science of Light Center at Cincinnati Children’s shows that lighting conditions can change how newborn eyes develop, with darkness fostering the development of more rods, the...
OcuDyne, of Brooklyn Park, Minnesota, reported Sept. 9 that it had successfully completed a pilot study using its Optic System to perform ophthalmic artery angioplasty in patients with geographic a...
A study in mice at the Science of Light Center at Cincinnati Children’s shows that lighting conditions can change how newborn eyes develop, with darkness fostering the development of more rods, the...
A new analysis of 2008 clinical study data has given a boost to Livionex’ topical drop candidate for cataracts, the John Moran Eye Center reported Aug. 16. The drop, called C-KAD, is a formulation ...
The status of the National Eye Institute (NEI) as a separate unit within the National Institutes of Health (NIH) would come to an end under a proposal by a US House committee chair to consolidate t...
Researchers at Oregon Health & Science University (OHSU) say they have discovered a connection between postsurgical ocular pain and levels of certain proteins found in patients’ tears. Some patient...
The status of the National Eye Institute (NEI) as a separate unit within the National Institutes of Health (NIH) would come to an end under a proposal by a US House committee chair to consolidate t...
Researchers at Oregon Health & Science University (OHSU) say they have discovered a connection between postsurgical ocular pain and levels of certain proteins found in patients’ tears. Some patient...
Researchers at the University of Rochester have found that blinking plays a critical role in visual perception, in addition to maintaining eye health. Their research was published in April 2024 in ...
Researchers at the University of Rochester have found that blinking plays a critical role in visual perception, in addition to maintaining eye health. Their research was published in April 2024 in ...
The virus that causes COVID-19 can breach the blood-retinal barrier, with potential long-term consequences for eye health, researchers at the University of Missouri School of Medicine have discover...
An analysis of more than 3,100 older adults, published May 23 in JAMA Ophthalmology, showed that low-dose aspirin taken for three years did not affect the incidence or progression of age-related ma...
Apellis Pharmaceuticals reported June 10 that Syfovre (pegcetacoplan injection), its treatment for geographic atrophy (GA), preserved visual function at 36 months in the GALE long-term extension st...
An analysis of more than 3,100 older adults, published May 23 in JAMA Ophthalmology, showed that low-dose aspirin administered for three years did not affect the incidence or progression of age-rel...
Apellis Pharmaceuticals reported June 10 that Syfovre (pegcetacoplan injection), its treatment for geographic atrophy (GA), preserved visual function at 36 months in the GALE long-term extension st...
The virus that causes COVID-19 can breach the blood-retinal barrier, with potential long-term consequences for eye health, researchers at the University of Missouri School of Medicine have discover...
Retina, The Journal of Retinal and Vitreous Diseases, has published new guidelines that represent best practices for injection of therapies into the suprachoroidal space (SCS). The article, publish...
Many companies participate in ARVO’s annual meeting to catch the attention of external researchers and propel their research program or clinical trials forward. Two such companies in 2024 were John...
Artificial intelligence was a prominent topic at the 2024 ARVO meeting. Discussions ranged from using AI in published ophthalmic research to employing it in early detection and monitoring of eye di...
The Weisenfeld and Cogan awards and lectures at the 2024 ARVO meeting put a spotlight on inflammation. Martine Jager, MD, PhD (Netherlands), received the Weisenfeld Award in recognition of her pion...
The National Eye Institute (NEI) announced April 8 that researchers from the Medical College of Georgia at Augusta University had established a database of the proteins found in the eye’s aqueous h...
Artificial intelligence can accurately and independently detect 100 percent of severe cases of retinopathy of prematurity (ROP), according to a study published March 7 in the journal JAMA Ophthalmo...
Oculogenex, a California company developing a regenerative gene therapy for age-related macular degeneration (AMD), is sending its preclinical work into space. The company’s gene therapy candidate ...
Sight loss in certain inherited eye diseases may be caused by gut bacteria, opening the door for potential treatment with antimicrobials, according to a new study in mice co-led by a researcher at ...
Oculogenex, a California company developing a regenerative gene therapy for age-related macular degeneration (AMD), is sending its preclinical work into space. The company’s gene therapy candidate ...
Sight loss in certain inherited eye diseases may be caused by gut bacteria, opening the door for potential treatment with antimicrobials, according to a new study in mice co-led by a researcher at ...
Researchers in Australia announced Feb. 5 that they had received a $35 million grant from the national government’s Medical Research Future Fund to support the development of a tissue-engineered co...
LambdaVision’s ninth planned space experiment launched Jan. 30 from Cape Canaveral for the International Space Station. LambdaVision, of Farmington, Connecticut, is trying to leverage microgravity ...
Researchers in Australia announced Feb. 5 that they had received a $35 million grant from the national government’s Medical Research Future Fund to support the development of a tissue-engineered co...
A recent study by investigators at Mass Eye and Ear of the Harvard Medical School Department of Ophthalmology revealed that the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes cornea...
LambdaVision’s ninth planned space experiment launched Jan. 30 from Cape Canaveral for the International Space Station. LambdaVision, of Farmington, Connecticut, is trying to leverage microgravity ...
Two ophthalmic researchers at the University of Colorado’s Anschutz Medical Campus are among nine winners of grants from the Anschutz Acceleration Initiative, a UC Anschutz program that grants awar...
A recent study by investigators at Mass Eye and Ear of the Harvard Medical School Department of Ophthalmology revealed that that administration of the neuropeptide α-melanocyte-stimulating hormone ...
Korean researchers were able to identify all children with autism, with no false positives, using an AI model based on 2D retinal images of the optic disc area. Their findings were published in the...
ECM Therapeutics, of Warrendale, Pennsylvania, reported Dec. 19 that it would collaborate with the Louis J. Fox Center for Vision Restoration on work to restore vision following optic nerve damage....
The National Eye Institute (NEI) announced Dec. 4 that it had chosen Richard Lee, MD, PhD, as the institute’s clinical director, overseeing clinical research and serving as clinical policy advisor....
Researchers at Doheny Eye Institute, in collaboration with researchers at UC Irvine, have discovered retinal capillary stiffening in early-stage diabetes in mice. Blocking this stiffening inhibited...
InMed Pharmaceuticals, of Vancouver, Canada, announced Nov. 29 that it had added to its pipeline INM-089, a cannabinoid analog, to investigate its potential treatment effect in age-related macular ...
Researchers at Doheny Eye Institute, in collaboration with researchers at UC Irvine, have discovered retinal capillary stiffening in early-stage diabetes in mice. Blocking this stiffening inhibited...
EarliTec Diagnostics reported Sept. 5 that The Journal of the American Medical Association (JAMA) had released study results for its eye tracking system for autism in two of its publications. The s...
EarliTec Diagnostics reported Sept. 5 that The Journal of the American Medical Association (JAMA) had released study results for its eye tracking system for autism in two of its publications. The s...
Investigators at Cedars-Sinai in Los Angeles say they’ve identified diabetes-associated epigenetic changes to the cornea, providing a new understanding of how the disease delays wound healing in th...
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.